# Progress Note 05 — Annual Wellness Visit, Subsequent

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Leonard Nimoy (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML017-SYN
- Date: 2026-10-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Carla Benedetti, MD
- Calendar frame: modern shifted

- Visit type: Annual Wellness Visit, Subsequent
- Services: HCPCS G0439 (subsequent annual wellness visit) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Subsequent annual wellness visit; no new complaints. **S**

## History of present illness

Mr. Nimoy is an 83-year-old man with COPD (GOLD 3, group B) who returns for his subsequent annual wellness visit, eight weeks after his six-month COPD review. His last annual wellness visit was with his previous primary care clinician more than a year ago. He completed the health risk assessment before the visit. He takes tiotropium-olodaterol two inhalations each morning and uses albuterol about twice a week, mostly before longer walks. He has had no flare-ups, antibiotic or prednisone courses, emergency visits, or hospital stays since his first visit in February. He keeps up the home exercise program from pulmonary rehabilitation, walking about 15 minutes twice a day and doing leg and arm exercises three times a week. He has no new concerns. **S**

| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit |
| Safety events | No falls, emergency visits, or hospital stays since February |
| Medicines | Tiotropium-olodaterol daily; albuterol about twice a week; no over-the-counter medicines or supplements |
| Active conditions | COPD, GOLD 3, group B, with no exacerbation this year; former smoker who quit about 30 years ago |
| Functional status | Independent in all activities of daily living; walks about 300 meters before stopping; uses a wheelchair for long distances |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Fair; better since rehabilitation |
| Psychosocial | Lives with his spouse; close family and friends; enjoys his photography and writing projects; no loneliness |
| Tobacco | Former smoker; no tobacco or vaping for about 30 years |
| Alcohol and drugs | No alcohol (AUDIT-C 0); no other drug use |
| Physical activity | Walks about 15 minutes twice a day and does the rehabilitation strength routine three times a week |
| Nutrition | Regular meals; weight stable; smaller meals when breathless |
| Sleep | About seven hours a night, sleeping flat on two pillows; no snoring or witnessed pauses reported |
| Activities of daily living | Independent; showers seated on a bench to save breath |
| Instrumental activities of daily living | Independent with medicines and finances; family drive him to longer appointments |
| Home safety | Single-story home; grab bars in the shower; smoke and carbon monoxide detectors working; no loose rugs |
| Falls | No falls this year |
| Hearing and vision | Some difficulty following conversation in noisy rooms; reading glasses; eye examination last year |
| Memory | No concerns |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever, night sweats, or unusual fatigue |
| Eyes | Negative | No change in vision with reading glasses |
| Ears, nose, mouth, and throat | Positive | Some difficulty hearing in noisy rooms; no sore mouth, hoarseness, or dry mouth from the inhaler |
| Cardiovascular | Negative | No chest pain, palpitations, orthopnea, or ankle swelling |
| Respiratory | Positive | Known breathlessness on longer walks and stairs; little cough and a small amount of clear morning sputum; no wheeze at rest |
| Gastrointestinal | Negative | No heartburn, swallowing trouble, or change in bowel habit |
| Genitourinary | Negative | No difficulty passing urine or retention since starting the inhaler |
| Musculoskeletal | Negative | No joint pain, back pain, or fractures |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Negative | No weakness, numbness, or memory change |
| Psychiatric | Negative | Mood good; no anxiety about breathing; PHQ-2 score 0 |
| Endocrine | Negative | No heat or cold intolerance, thirst, or frequent urination |
| Hematologic | Negative | No easy bruising or bleeding |

13 systems reviewed. **S**

## Current medications

- Albuterol 90 mcg/actuation inhaler, two inhalations as needed for breathlessness (prescribed by his previous clinician; used once or twice most days before intake) **S**
- Tiotropium-olodaterol 2.5/2.5 mcg soft mist inhaler, two inhalations once daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 130/76 mmHg; pulse 76 bpm; respirations 18/min; temperature 36.7 °C; oxygen saturation 94% on room air; weight 80.6 kg; BMI 23.6 kg/m². All vital signs are synthetic.

PHQ-2: 0; Mini-Cog: 5; AUDIT-C: 0. All results are synthetic.

## Immunizations given today

- High-dose influenza vaccine, 2026-2027 season **S**
- RSV vaccine, single dose **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Tall, alert, and engaged; speaks in full sentences; weight 80.6 kg, BMI 23.6 |
| Eyes | Pupils equal and reactive; near vision 20/30 with reading glasses |
| Ears | Canals clear; whispered-voice test missed on the left, passed on the right |
| Neck | No jugular venous distension; no thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm at 76 per minute; distant heart sounds; no murmur; no edema |
| Respiratory | Hyperinflated chest; reduced breath sounds throughout; prolonged expiration; no wheeze or crackles; oxygen saturation 94 percent on room air |
| Abdomen | Soft and non-tender; no masses |
| Musculoskeletal | Timed Up and Go 11 seconds; rises from a chair without using his arms |
| Neurological | Alert and oriented; gait steady; Mini-Cog 5 of 5 |
| Psychiatric | Euthymic and engaged; judgment and insight intact |
| Skin | No cyanosis or clubbing; no suspicious lesions |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Subsequent annual wellness visit completed**. Health risk assessment reviewed and a written prevention plan given. Depression, alcohol, cognitive, and fall-risk screens are negative. Possible hearing loss on the left on the whispered-voice test. **S**
   - Audiology for formal hearing testing.
   - Next annual wellness visit in one year.
2. **COPD, GOLD 3, group B** (J44.9). Stable on tiotropium-olodaterol, with no exacerbation this year and the gains from rehabilitation kept up. Resting oxygen saturation 94 percent. **S**
   - Continue tiotropium-olodaterol and albuterol as needed.
   - Influenza and RSV vaccines today.
   - Next COPD review, with yearly spirometry, in February as planned.
3. **Former smoker** (Z87.891). No tobacco for about 30 years. Not eligible for lung cancer screening, because he quit more than 15 years ago. **S**
   - No lung cancer screening; review only if the criteria change.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, this season | Completed today | High-dose vaccine given today |
| RSV vaccine | Completed today | Single dose given today; recommended for all adults 75 and older, and his COPD adds to the risk |
| Pneumococcal vaccine | Up to date | PCV20 given in May; no further doses needed |
| COVID-19 vaccine, this season | Due | Recommended at his age and with COPD; he will get it at the pharmacy next week |
| Recombinant zoster vaccine | Up to date | Two-dose series completed in the past |
| Tetanus, diphtheria, and pertussis booster | Up to date | Tdap within the past ten years |
| Lung cancer screening | Not indicated | More than 20 pack-years, but he quit more than 15 years ago, so he does not meet the criteria; he is also over 80 |
| Abdominal aortic aneurysm screening | Not indicated | One-time ultrasound is recommended for men 65 to 75 who have ever smoked; he is 83, and no prior result is on file. Not offered |
| Colorectal cancer screening | Not indicated | Colonoscopy normal more than ten years ago; at 83 screening is a selective decision, and he chose not to continue |
| Prostate cancer screening | Not indicated | Not recommended after 70 |
| Bone density (DXA) | Ordered | Evidence is insufficient for routine screening of men, but COPD and low activity raise fracture risk; ordered after discussion |
| Hepatitis C screening | Not indicated | Universal one-time screening is recommended for adults 18 to 79; no risk factors |
| Depression screening | Completed today | PHQ-2 score 0; PHQ-9 3 in February |
| Alcohol misuse screening | Completed today | AUDIT-C score 0 |
| Cognitive assessment | Completed today | Mini-Cog 5 of 5 |
| Falls prevention | Completed today | Timed Up and Go 11 seconds; no falls; home exercise from rehabilitation continues |
| Hearing | Referred | Whispered-voice test missed on the left; audiology arranged |
| Eye examination | Up to date | Eye examination last year |

## Advance care planning

Voluntary advance care planning discussion of about 25 minutes, with his consent. We talked about what COPD at this stage can mean over the coming years, including flare-ups that may need hospital care, and why it helps to plan ahead. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying at home, keeping up his creative work, and being told plainly about his health so he can make his own decisions. He chose not to record specific treatment preferences today. The plan will be revisited yearly and after any hospital stay. **S**

## Guideline basis

- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2025 report (2025), Global Initiative for Chronic Obstructive Lung Disease
- CMID: Clinical Monitoring Intelligence Database, chronic obstructive pulmonary disease monograph (2026), Aether Forge
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
- Medicare Wellness Visits (Medicare Learning Network) (2026), Centers for Medicare & Medicaid Services
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force

## Follow-up

- COVID-19 vaccine at the pharmacy next week. Audiology and the DXA scan to be booked. COPD review with yearly spirometry in February. Next annual wellness visit in one year. **S**

